Quote - "PTX-100 is much further advanced. It’s already passed its phase one study, in which it was found to be safe and effective within a group of patients with advanced cancers who saw little results from previous therapies. It was well-tolerated and stabilised disease progression for solid tumours, mostly those of the gastrointestinal tract.
PTX-100 has now entered phase 1B which is led by the world-renowned oncologist, Professor Miles Prince. "
PTX Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
